Ursula A Matulonis (Ursula Matulonis)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 35

Top Topics

Endometrial Cancer

Sensitive Detection

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, Alexandre Andre Balieiro Anastacio da Costa, Doga C Gulhan, Andrea E Wahner Hendrickson, Bose S Kochupurakkal, David L Kolin, Elise C Kohn, Joyce F Liu, Richard T Penson, Elizabeth H Stover, Jennifer Curtis, Hannah Sawyer, Madeline Polak, Dipanjan Chowdhury, Alan D' Andrea, Anniina Färkkilä, Geoffrey I Shapiro, Ursula A Matulonis
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses. JCO precision oncology 8 (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Giorgio Bogani, Robert L Coleman, Ignace Vergote, Toon Van Gorp, Isabelle L Ray-Coquard, Ana Oaknin, Ursula A Matulonis, David O'Malley, Francesco Raspagliesi, Giovanni Scambia, Bradley J Monk
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, Alexandre Andre Balieiro Anastacio da Costa, Doga C Gulhan, Andrea E Wahner Hendrickson, Bose S Kochupurakkal, David L Kolin, Elise C Kohn, Joyce F Liu, Richard T Penson, Elizabeth H Stover, Jennifer Curtis, Hannah Sawyer, Madeline Polak, Dipanjan Chowdhury, Alan D' Andrea, Anniina Färkkilä, Geoffrey I Shapiro, Ursula A Matulonis
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses. JCO precision oncology 8 (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Giorgio Bogani, Robert L Coleman, Ignace Vergote, Toon Van Gorp, Isabelle L Ray-Coquard, Ana Oaknin, Ursula A Matulonis, David O'Malley, Francesco Raspagliesi, Giovanni Scambia, Bradley J Monk
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase 1/2 study of combined BCL-xL and MEK inhibition with navitoclax and trametinib in KRAS or NRAS mutant advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, Alexandre Andre Balieiro Anastacio da Costa, Doga C Gulhan, Andrea E Wahner Hendrickson, Bose S Kochupurakkal, David L Kolin, Elise C Kohn, Joyce F Liu, Richard T Penson, Elizabeth H Stover, Jennifer Curtis, Hannah Sawyer, Madeline Polak, Dipanjan Chowdhury, Alan D' Andrea, Anniina Färkkilä, Geoffrey I Shapiro, Ursula A Matulonis
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses. JCO precision oncology 8 (2024)
Bradley J Monk, Antonio Gonzáles Martin, Lynn Buckley, Ursula A Matulonis, B J Rimel, Xiaohua Wu, Kathleen N Moore, Mansoor R Mirza
Safety and management of niraparib monotherapy in ovarian cancer clinical trials. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Martin S Taylor, Connie Wu, Peter C Fridy, Stephanie J Zhang, Yasmeen Senussi, Justina Clarinda Wolters, Tatiana Cajuso, Wen-Chih Cheng, John D Heaps, Bryant D Miller, Kei Mori, Limor Cohen, Hua Jiang, Kelly R Molloy, Brian T Chait, Michael G Goggins, Irun Bhan, Joseph W Franses, Xiaoyu Yang, Mary-Ellen Taplin, Xinan Wang, David Chistopher Christiani, Bruce E Johnson, Matthew L Meyerson, Ravindra Uppaluri, Ann Marie Egloff, Elyssa N Denault, Laura M Spring, Tian-Li Wang, Ie-Ming Shih, Jennifer E Fairman, Euihye Jung, Kshitij S Arora, Osman H Yilmaz, Sonia Cohen, Tatyana Sharova, Gary Chi, Bryanna L Norden, Yuhui Song, Linda T Nieman, Leontios Pappas, Aparna Raj Parikh, Matthew R Strickland, Ryan B Corcoran, Tomas Mustelin, George Eng, Ömer H Yilmaz, Ursula A Matulonis, Steven J Skates, Bo R Rueda, Ronny Drapkin, Samuel J Klempner, Vikram Deshpande, David Tsai Ting, Michael P Rout, John LaCava, David R Walt, Kathleen H Burns
Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker. Cancer discovery (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Susumu Shimoyama, Ken Okada, Toshifumi Kimura, Yasushi Morohashi, Shinji Nakayama, Sayaka Kemmochi, Keiko Makita-Suzuki, Ursula A Matulonis, Mikinaga Mori
FF-10850, a Novel Liposomal Topotecan Achieves Superior Anti-tumor Activity via Macrophage- and Ammonia-mediated Payload Release in the Tumor Microenvironment. Molecular cancer therapeutics (2023)
Giorgio Bogani, Robert L Coleman, Ignace Vergote, Toon Van Gorp, Isabelle L Ray-Coquard, Ana Oaknin, Ursula A Matulonis, David O'Malley, Francesco Raspagliesi, Giovanni Scambia, Bradley J Monk
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Nicoletta Colombo, Toon Van Gorp, Ursula A Matulonis, Ana Oaknin, Rachel N Grisham, Gini F Fleming, Alexander B Olawaiye, Dorothy D Nguyen, Andrew E Greenstein, Joseph M Custodio, Hristina I Pashova, Iulia C Tudor, Domenica Lorusso
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Marcin Straczkiewicz, Nancy L Keating, Embree Thompson, Ursula A Matulonis, Susana M Campos, Alexi A Wright, Jukka-Pekka Onnela
Open-Source, Step-Counting Algorithm for Smartphone Data Collected in Clinical and Nonclinical Settings: Algorithm Development and Validation Study. JMIR cancer 9 (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Reply to Z.R. McCaw et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Min Liu, Nabihah Tayob, Livius Penter, MacLean Sellars, Anna Tarren, Vipheaviny Chea, Isabel Carulli, Teddy Huang, Shuqiang Li, Su-Chun Cheng, Phuong Le, Laura Frackiewicz, Julia Fasse, Courtney Qi, Joyce F Liu, Elizabeth H Stover, Jennifer Curtis, Kenneth J Livak, Donna S Neuberg, Guanglan Zhang, Ursula A Matulonis, Catherine J Wu, Derin B Keskin, Panagiotis A Konstantinopoulos
Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Mansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, Andrés Redondo, Michel Fabbro, Bobbie J Rimel, Jørn Herrstedt, Amit M Oza, Ulrich Canzler, Jonathan S Berek, Antonio Gonzáles Martin, Phillipe Follana, Rosemary Lord, Masoud Azodi, Kasey Estenson, Zebin Wang, Yong Li, Divya Gupta, Ursula A Matulonis, Bin Feng
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects. Cancer research communications 2 (11) (2022)
Joyce F Liu, Mark F Brady, Ursula A Matulonis, Austin Miller, Elise C Kohn, Elizabeth M Swisher, David Cella, William P Tew, Noelle G Cloven, Carolyn Y Muller, David P Bender, Richard G Moore, David P Michelin, Steven E Waggoner, Melissa A Geller, Keiichi Fujiwara, Stacy D D'Andre, Michael E Carney, Angeles A Secord, Katherine M Moxley, Michael A Bookman
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Mansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, Andrés Redondo, Michel Fabbro, Bobbie J Rimel, Jørn Herrstedt, Amit M Oza, Ulrich Canzler, Jonathan S Berek, Antonio Gonzáles Martin, Phillipe Follana, Rosemary Lord, Masoud Azodi, Kasey Estenson, Zebin Wang, Yong Li, Divya Gupta, Ursula A Matulonis, Bin Feng
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects. Cancer research communications 2 (11) (2022)
Felipe Batalini, Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann, Lewis C Cantley, Geoffrey I Shapiro, Viktor Adalsteinsson, Eric P Winer, Panagiotis A Konstantinopoulos, Alan D' Andrea, Elizabeth M Swisher, Ursula A Matulonis, Gerburg M Wulf, Erica L Mayer
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Panagiotis A Konstantinopoulos, Elizabeth K Lee, Niya Xiong, Carolyn Krasner, Susana Campos, David L Kolin, Joyce F Liu, Neil Horowitz, Alexi A Wright, Sara Bouberhan, Richard T Penson, Oladapo O Yeku, Brittany Bowes, Hope Needham, Martin Hayes, Hannah Sawyer, Madeline Polak, Meghan Shea, Su-Chun Cheng, Cesar M Castro, Ursula A Matulonis
A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Felipe Batalini, Doga C Gulhan, Victor Y Mao, Antuan V Tran, Madeline Polak, Niya Xiong, Nabihah Tayob, Nadine M Tung, Eric P Winer, Erica L Mayer, Stian Knappskog, Per Eystein Lønning, Ursula A Matulonis, Panagiotis A Konstantinopoulos, David B Solit, Helen H Won, Hans Petter Eikesdal, Peter J Park, Gerburg M Wulf
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Panagiotis A Konstantinopoulos, Antonio Gonzalez-Martin, Felipe Melo Cruz, Michael L Friedlander, Rosalind M Glasspool, Domenica Lorusso, Christian Marth, Bradley J Monk, Jae-Weon Kim, Patsy Hinson, Olga Ajipa, Vincent Pretre, Yu Han, Ursula A Matulonis
EPIK-O/ENGOT-OV61: Alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study). Future oncology (London, England) (2022)
Antonio Gonzáles Martin, Ursula A Matulonis, Jacob Korach, Mansoor Raza Mirza, Kathleen M Moore, Xiaohua Wu, Whitney York, Divya Gupta, Stanislav Lechpammer, Bradley J Monk
Niraparib treatment for patients with BRCA -mutated ovarian cancer: review of clinical data and therapeutic context. Future oncology (London, England) 18 (23) (2022)
Rebecca L Porter, Ursula A Matulonis
Checkpoint Blockade: Not Yet NINJA Status in Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (33) (2021)